Investor mix
3 investors on record; lead investors include PBM Capital.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 33% |
| Other / undisclosed | 2 | 67% |
Gene therapy company restoring immune balance to treat chronic inflammation
3 investors on record; lead investors include PBM Capital.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 33% |
| Other / undisclosed | 2 | 67% |